Worth Watching Stocks: CVS Health Corporation (CVS), Under Armour, Inc. (UAA), Philip Morris International Inc. (PM)

CVS Health Corporation (CVS) saw its value decrease by -0.45% as the stock dropped $-0.38 to finish the day at a closing price of $83.54. The stock was lighter in trading and has fluctuated between $69.3-$106.67 per share for the past year. The shares, which traded within a range of $83.2 to $84.72 during the day, are down by -3.12% in the past three months and down by -13.36% over the past six months. It is currently trading 3.6% above its 20 day moving average and 6.36% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $87.95 a share over the next twelve months. The current relative strength index (RSI) reading is 67.54.The technical indicator lead us to believe there will be no major movement any time soon, hold.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Under Armour, Inc. (UAA) shares were down in last trading by -2.62% to $29.35. It experienced lighter than average volume on day. The stock decreased in value by almost -4.43% over the past week and fell -5.32% in the past month. It is currently trading -4.71% below its 50 day moving average and -21.42% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -38.79% decrease in value from its one year high of $47.95. The RSI indicator value of 36.64, lead us to believe that it is a hold for now.

Under Armour, Inc. together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot, cold, and in between the extremes. It provides various footwear products, including football, baseball, lacrosse, softball and soccer cleats, slides, performance training, running, basketball, and outdoor footwear. The company also offers accessories, which include headwear, bags, and gloves; and digital fitness platform licenses and subscriptions, as well as digital advertising, as well as licenses its brands. It primarily provides its products under the UA Logo, UNDER ARMOUR, UA, ARMOUR, HEATGEAR, COLDGEAR, ALLSEASONGEAR, PROTECT THIS HOUSE, and I WILL, as well as ARMOURBITE, ARMOURSTORM, ARMOUR FLEECE, and ARMOUR BRA trademarks. The company sells its products through wholesale channels, including national and regional sporting goods chains, independent and specialty retailers, department store chains, institutional athletic departments, and leagues and teams, as well as independent distributors; and directly to consumers through a network of brand and factory house stores, and Website. Under Armour, Inc. was founded in 1996 and is headquartered in Baltimore, Maryland.

Philip Morris International Inc. (PM) traded within a range of $92.54 to $93.52 after opening the day at $92.6. The company has seen its stock increase in value by 2.19% so far this year. The stock was up close to 1.22% on active volume in last trading session and closed at $93.49 per share. After the recent gain, the stock is currently holding -8.31% below its 52 week high of $104.2 and 15.47% above its 12-month low of $84.46. The shares are down by over -0.99% in the last three months, and the RSI indicator value of 67.03 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other tobacco products, and other nicotine-containing products. Its portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. The company also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Hope in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; Best in Serbia; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia. It markets and sells its products in approximately 180 countries in the European Union, Eastern Europe, the Middle East, Africa, Asia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is based in New York, New York.

 

Trader Alert: CVS Health Corporation (CVS), Arconic Inc. (ARNC), Monster Beverage Corporation (MNST)

CVS Health Corporation (CVS) retreated with the stock falling -0.75% or $-0.62 to close at $81.98 on light trading volume of 4.58M compared its three months average trading volume of 8.45M. The Woonsocket Rhode Island 02895 based company operating under the Health Care Plans industry has been trending down for the last 52 weeks, with the shares price now -12.61% down for the period and up by 3.89% so far this year. With price target of $87.95 and a 18.3% rebound from 52-week low, CVS Health Corporation has plenty of upside potential, making it a hold with a view buy.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Arconic Inc. (ARNC) gained $0.13 to close the day at a new closing price of $21.13, a 0.62% increase in value from its previous closing price that moved the stock 55.39% above its 52 week low of $13.81. A total of 4.56M shares exchanged hands during the day compared with its three month average trading volume of 7.05M. The stock, which fluctuated between $20.89 and $21.23 during the day, currently situated -17.39% below its 52 week high. The stock is down by -0.28% in the past one month and up by 5.92% over the past three months. With a one year target estimate of $23.2 and RSI of 62.1, the stock still has upside potential, making it a hold for now.

Alcoa Inc. develops, manufactures, and sells engineered products and solutions for the aerospace, industrial gas turbine, commercial transportation, and oil and gas markets worldwide. It offers airfoils, fasteners, rings, forgings, extrusions, alloys, and industrial gas turbines; and titanium aero ingots and mill products, as well as multi-material airframe subassemblies, technologies, and materials, such as 3D printing and titanium aluminides. The company also provides aluminum sheets and plates for the aerospace, automotive, commercial transportation, brazing, and industrial markets. In addition, it provides forged aluminum truck wheels and other transportation products; aluminum curtain walls and front entry systems, including self-cleaning facades, and blast proof and hurricane resistant entrances for building and construction markets; and extrusions for trains, buildings, and various industrial applications. Alcoa Inc. was founded in 1888 and is based in New York, New York.

Monster Beverage Corporation (MNST) shares were up in last trading by 3.25% to $44.51. It experienced higher than average volume on day. The stock decreased in value by almost -2.43% over the past week and fell -1.09% in the past month. It is currently trading 0.17% above its 50 day moving average and -8.2% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -19.8% decrease in value from its one year high of $55.5. The RSI indicator value of 51.94, lead us to believe that it is a hold for now.

Monster Beverage Corporation, through its subsidiaries, develops, markets, sells, and distributes energy drink beverages and its concentrates in the United States and internationally. It operates through three segments: Finished Products, Concentrate, and Other. The company provides carbonated energy, and non-carbonated dairy based coffee and energy drinks to full service beverage distributors, retail grocery and specialty chains, wholesalers, club stores, drug chains, mass merchandisers, convenience chains, health food distributors, food service customers, and the military; and concentrates and/or beverage bases to authorized bottling and canning operations. Monster Beverage Corporation sells its products under the Monster Energy, Nalu, Monster Rehab, NOS, Monster Energy Extra Strength Nitrous Technology, Full Throttle, Java Monster, Burn, Muscle Monster, Mother, Mega Monster Energy, Ultra, Punch Monster, Play and Power Play, Juice Monster, Gladiator, M3, Relentless, Übermonster, Samurai, BU, and BPM brands. The company was formerly known as Hansen Natural Corporation and changed its name to Monster Beverage Corporation in January 2012. Monster Beverage Corporation was founded in 1985 and is headquartered in Corona, California.

 

Three Movers to Watch for: CF Industries Holdings, Inc. (CF), Time Warner Inc. (TWX), CVS Health Corporation (CVS)

CF Industries Holdings, Inc. (CF) grew with the stock adding 0.94% or $0.32 to close at $34.51 on active trading volume of 5.9M compared its three months average trading volume of 5.97M. The Deerfield Illinois 60015 based company operating under the Agricultural Chemicals industry has been trending up for the last 52 weeks, with the shares price now 13.76% up for the period and up by 9.63% so far this year. With price target of $27.49 and a 70.43% rebound from 52-week low, CF Industries Holdings, Inc. has plenty of upside potential, making it a hold with a view buy.

CF Industries Holdings, Inc. manufactures and distributes nitrogen fertilizers and other nitrogen products worldwide. The company operates through Ammonia, Granular Urea, UAN, AN, Other, and Phosphate segments. Its primary nitrogen fertilizer products include ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate. The company also provides diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia as well as compound fertilizer product, such as nitrogen, phosphorus, and potassium fertilizer. It offers products primarily to cooperatives, independent fertilizer distributors, farmers, and industrial users. CF Industries Holdings, Inc. was founded in 1946 and is based in Deerfield, Illinois.

Time Warner Inc. (TWX) gained $0.17 to close the day at a new closing price of $93.85, a 0.18% increase in value from its previous closing price that moved the stock 72.58% above its 52 week low of $55.53. A total of 5.78M shares exchanged hands during the day compared with its three month average trading volume of 6.93M. The stock, which fluctuated between $93.45 and $94.4 during the day, currently situated -3.46% below its 52 week high. The stock is down by -0.87% in the past one month and up by 17.95% over the past three months. With a one year target estimate of $103.4 and RSI of 48.86, the stock still has upside potential, making it a hold for now.

Time Warner Inc. operates as a media and entertainment company in the United States and internationally. It operates through three segments: Turner, Home Box Office, and Warner Bros. The Turner segment owns and operates a portfolio of cable television networks and related properties that offer entertainment, sports, kids, and news programming on television and digital platforms for consumers. It operates approximately 180 channels in 200 countries. The Turner segment’s networks and related properties include TNT, TBS, Adult Swim, truTV, Turner Classic Movies, Turner Sports, Cartoon Network, Boomerang, CNN, and HLN; and digital media properties comprise bleacherreport.com, NBA.com, NBA Mobile, NCAA.com, PGA.com, tntdrama.com, TBS.com, adultswim.com, and cartoonnetwork.com. It also licenses original programming to subscription-video-on-demand (SVOD) services and other over-the-top services, and its brands and characters for consumer products other business ventures. This segment serves cable system operators, satellite service distributors, telephone companies, and other distributors. The Home Box Office segment provides premium pay and basic tier television services comprising HBO and Cinemax; sells its original programming through physical and digital formats; and licenses home entertainment and content to international television networks and SVOD services. As of December 31, 2015, this segment had 49 million domestic subscribers. The Warner Bros. segment produces, distributes, and licenses television programming and feature films; distributes digital and physical home entertainment products; and produces and distributes videogames, as well as licenses consumer products and brands. The company was formerly known as AOL Time Warner, Inc. and changed its name to Time Warner Inc. in 2003. Time Warner Inc. was founded in 1985 and is headquartered in New York, New York.

CVS Health Corporation (CVS) shares were down in last trading by -0.21% to $82.6. It experienced lighter than average volume on day. The stock increased in value by almost 1.45% over the past week and grew 3.6% in the past month. It is currently trading 5.09% above its 50 day moving average and -9.17% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -21.84% decrease in value from its one year high of $106.67. The RSI indicator value of 66.66, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks Trend Analysis: CVS Health Corporation (CVS), Corning Incorporated (GLW), Marathon Oil Corporation (MRO)

CVS Health Corporation (CVS) managed to rebound with the stock climbing 1.19% or $0.97 to close the day at $82.67 on light trading volume of 7.05M shares, compared to its three month average trading volume of 8.43M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -11.33%, compared to the industry which has advanced 13.39% over the same period. With RSI of 66.04, the stock should still continue to rise and get closer to its one year target estimate of $87.39, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Corning Incorporated (GLW) grew with the stock adding 0.08% or $0.02 to close at $24.49 on light trading volume of 7.04M compared its three months average trading volume of 7.86M. The Corning New York 14831 based company operating under the Diversified Electronics industry has been trending up for the last 52 weeks, with the shares price now 45.17% up for the period and up by 0.91% so far this year. With price target of $23.56 and a 55.79% rebound from 52-week low, Corning Incorporated has plenty of upside potential, making it a hold with a view buy.

Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for liquid crystal displays (LCDs) used in LCD televisions, notebook computers, and flat panel desktop monitors. The Optical Communications segment manufactures optical fiber and cable; and hardware and equipment products comprising cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories. This segment also offers subscriber demarcation, connection and protection devices, passive solutions, and outside plant enclosures; and coaxial RF interconnects for the cable television industry and microwave applications. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary, and gasoline and diesel applications. The Specialty Materials segment manufactures products that provide approximately 150 material formulations for glass, glass ceramics, and fluoride crystals. The Life Sciences segment manufactures and supplies scientific laboratory products consisting of consumables, such as plastic vessels, specialty surfaces, and media, as well as general labware and equipment for cell culture research, bioprocessing, genomics, drug discovery, microbiology, and chemistry. It also engages in a pharmaceutical glass vessel and a tubing business; and precision materials’ non-LCD business, as well as precision laser cutting/shaping technologies, and flow reactors and adjacency businesses for glass. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

Marathon Oil Corporation (MRO) managed to rebound with the stock climbing 0.46% or $0.08 to close the day at $17.48 on higher than average trading volume of 6.97M shares, compared to its three month average trading volume of 15.95M. The Houston Texas 77056 based company has been outperforming the independent oil & gas companies by 11.5543% for last three months and its recent gains have pushed the stock slightly up 0.98% YTD, versus the independent oil & gas industry which is down -0.72% for the same period. The RSI of 48.76 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Marathon Oil Corporation operates as an energy company. It operates through three segments: North America E&P, International E&P, and Oil Sands Mining. The North America E&P segment develops, explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in North America. The International Exploration and Production segment explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in Equatorial Guinea, Gabon, the Kurdistan Region of Iraq, Libya, and the United Kingdom; and produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol in Equatorial Guinea. The Oil Sands Mining segment mines, extracts, and transports bitumen from oil sands deposits in Alberta and Canada; and upgrades the bitumen to produce and market synthetic crude oil and vacuum gas oil. As of December 31, 2015, it had rights to participate in developed and undeveloped leases totaling approximately 32,000 net acres. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in July 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.

 

Traders Recap: MetLife, Inc. (MET), Chevron Corporation (CVX), CVS Health Corporation (CVS)

MetLife, Inc. (MET) failed to extend gains with the stock declining -0.89% or $-0.48 to close the day at $53.7 on higher than average trading volume of 6.94M shares, compared to its three month average trading volume of 6.51M. The New York New York 10166 based company has been outperforming the life insurance companies by 14.5903% for last three months and its recent gains have offset losses to -0.35% YTD, versus the life insurance industry which is up 1.13% for the same period. The RSI of 49.06 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Chevron Corporation (CVX) had a light trading with around 6.89M shares changing hands compared to its three month average trading volume of 7.04M. The stock traded between $115.11 and $116.36 before closing at the price of $115.84 with -0.86% change on the day. The San Ramon California 94583 based company is currently trading 60.62% above its 52 week low of $75.33 and -2.66% below its 52 week high of $119. Both the RSI indicator and target price of 51.62 and $121.46 respectively, lead us to believe that it should be put on hold over the coming weeks.

Chevron Corporation, through its subsidiaries, engages in integrated energy, chemicals, and petroleum operations worldwide. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, and production of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as operates a gas-to-liquids plant. The Downstream segment engages in refining crude oil into petroleum products; marketing crude oil and refined products; transporting crude oil and refined products through pipeline, marine vessel, motor equipment, and rail car; and manufacturing and marketing commodity petrochemicals, and fuel and lubricant additives, as well as plastics for industrial uses. It is also involved in the cash management and debt financing activities; corporate administrative operations; insurance operations; real estate activities; and technology businesses. Further, the company holds interests in power plants, as well as operates geothermal plants; and engages in the transportation of refined products primarily in the coastal waters of the United States. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

CVS Health Corporation (CVS) traded within a range of $81.16 to $82.38 after opening the day at $82.2. The company has seen its stock increase in value by 3.54% so far this year. The stock was down close to -0.61% on light volume in last trading session and closed at $81.7 per share. After the recent fall, the stock is currently holding -22.69% below its 52 week high of $106.67 and 17.89% above its 12-month low of $69.3. The shares are down by over -4.97% in the last three months, and the RSI indicator value of 64.11 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks Trending Alert: Denbury Resources Inc. (DNR), American Airlines Group Inc. (AAL), CVS Health Corporation (CVS)

Denbury Resources Inc. (DNR) saw its value decrease by -0.78% as the stock dropped $-0.03 to finish the day at a closing price of $3.81. The stock was lighter in trading and has fluctuated between $0.86-$4.8 per share for the past year. The shares, which traded within a range of $3.78 to $3.94 during the day, are up by 17.59% in the past three months and up by 18.32% over the past six months. It is currently trading -1.27% below its 20 day moving average and 14.44% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $3.21 a share over the next twelve months. The current relative strength index (RSI) reading is 57.21.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Denbury Resources Inc. operates as an independent oil and natural gas company in the United States. The company primarily focuses on enhanced oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. As of December 31, 2015, the company had 288.6 million barrels of oil equivalent of estimated proved oil and natural gas reserves. Denbury Resources Inc. was founded in 1951 and is headquartered in Plano, Texas.

American Airlines Group Inc. (AAL) shares were up in last trading by 0.7% to $46.21. It experienced higher than average volume on day. The stock decreased in value by almost -2.2% over the past week and fell -0.47% in the past month. It is currently trading 2.17% above its 50 day moving average and 22.79% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -8.75% decrease in value from its one year high of $50.64. The RSI indicator value of 46.93, lead us to believe that it is a hold for now.

American Airlines Group Inc., through its subsidiaries, operates in the airline industry. As of December 31, 2015, the company operated a mainline fleet of 946 aircraft. It serves 350 destinations in approximately 50 countries. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013. American Airlines Group Inc. was founded in 1934 and is headquartered in Fort Worth, Texas.

CVS Health Corporation (CVS) traded within a range of $80.94 to $82.46 after opening the day at $81.41. The company has seen its stock increase in value by 4.17% so far this year. The stock was up close to 0.96% on light volume in last trading session and closed at $82.2 per share. After the recent gain, the stock is currently holding -22.22% below its 52 week high of $106.67 and 18.61% above its 12-month low of $69.3. The shares are down by over -4.49% in the last three months, and the RSI indicator value of 59.82 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks To Watch: CVS Health Corporation (CVS), Synergy Pharmaceuticals Inc. (SGYP), Alexion Pharmaceuticals, Inc. (ALXN)

CVS Health Corporation (CVS) traded within a range of $78.8 to $81.52 after opening the day at $79.85. The company has seen its stock increase in value by 3.18% so far this year. The stock was up close to 2.09% on active volume in last trading session and closed at $81.42 per share. After the recent gain, the stock is currently holding -22.96% below its 52 week high of $106.67 and 17.49% above its 12-month low of $69.3. The shares are down by over -5.08% in the last three months, and the RSI indicator value of 58.02 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Synergy Pharmaceuticals Inc. (SGYP) failed to extend gains with the stock declining -1.35% or $-0.09 to close the day at $6.59 on active trading volume of 8.74M shares, compared to its three month average trading volume of 3.96M. The New York New York 10170 based company has been outperforming the drug manufacturers – other group over the past 52 weeks, with the stock gaining 30.5%, compared to the industry which has dropped -33.25% over the same period. With RSI of 70.83, the stock should still continue to rise and get closer to its one year target estimate of $10.8, making it a hold for now.

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333, which is in Phase II clinical trials to treat opioid induced constipation, as well as in Phase Ib clinical trials to treat ulcerative colitis. The company has a research collaboration with BIND Therapeutics, Inc. to develop ACCURINS for treatment of a range of cells with novel therapeutic payloads. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.

Alexion Pharmaceuticals, Inc. (ALXN) gained $12.07 to close the day at a new closing price of $139.18, a 9.5% increase in value from its previous closing price that moved the stock 27.55% above its 52 week low of $109.12. A total of 8.71M shares exchanged hands during the day compared with its three month average trading volume of 2.89M. The stock, which fluctuated between $133 and $141.41 during the day, currently situated -25.81% below its 52 week high. The stock is up by 11.41% in the past one month and up by 10.89% over the past three months. With a one year target estimate of $168.69 and RSI of 65.74, the stock still has upside potential, making it a hold for now.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia (HPP); and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company also conducts Phase IV clinical trials on Soliris for the treatment of PNH registry; Phase III clinical trials for the treatment of myasthenia gravis, neuromyelitis optica spectrum disorder, and delayed kidney transplant graft function; and Phase II clinical trials for antibody mediated rejection in presensitized renal transplant patients. It develops cPMP (ALXN 1101) that is in Phase II/III trial for treating metabolic disorders; and ALXN 1007, a novel humanized antibody in Phase II clinical trial for the treatment of anti-phospholipid syndrome and graft versus host disease. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other health care providers, as well as governments and government agencies in the United States, Europe, the Asia Pacific, and internationally. Alexion Pharmaceuticals, Inc. has agreements with X-Chem Pharmaceuticals (X-Chem) to identify novel drug candidates from X-Chem’s proprietary drug discovery engine; Moderna Therapeutics, Inc. (Moderna) that provides the option to purchase drug products for clinical development commercialization of Moderna’s messenger RNA therapeutics to treat rare diseases; and Ensemble Therapeutics Corporation for the identification, development, and commercialization of therapeutic candidates based on specific drug targets. The company was founded in 1992 and is headquartered in New Haven, Connecticut.

 

Stocks Trend Analysis: CVS Health Corporation (CVS), ACADIA Pharmaceuticals Inc. (ACAD), ARIAD Pharmaceuticals, Inc. (ARIA)

CVS Health Corporation (CVS) failed to extend gains with the stock declining -0.75% or $-0.6 to close the day at $79.75 on light trading volume of 7.1M shares, compared to its three month average trading volume of 8.35M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -16.07%, compared to the industry which has advanced 6.6% over the same period. With RSI of 51.91, the stock should still continue to rise and get closer to its one year target estimate of $87.1, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

ACADIA Pharmaceuticals Inc. (ACAD) grew with the stock adding 11.02% or $3.17 to close at $31.94 on active trading volume of 7.01M compared its three months average trading volume of 2.67M. The company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -7.31% down for the period and up by 10.75% so far this year. With price target of $41.73 and a 91.95% rebound from 52-week low, ACADIA Pharmaceuticals Inc. has plenty of upside potential, making it a hold with a view buy.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer’s disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

ARIAD Pharmaceuticals, Inc. (ARIA) managed to rebound with the stock climbing 5.58% or $0.69 to close the day at $13.06 on higher than average trading volume of 6.99M shares, compared to its three month average trading volume of 6.57M. The Cambridge Massachusetts 02139 based company has been outperforming the biotechnology companies by -2.2709% for last three months and its recent losses have trimmed gains to 4.98% YTD, versus the biotechnology industry which is up 2.5% for the same period. The RSI of 63.04 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, the European Union, Australia, Switzerland, Israel, and Canada. The company also develops Brigatinib, an investigational inhibitor of anaplastic lymphoma kinase for the treatment of various patients with a form of non-small cell lung cancer; and AP32788, for treating non-small cell lung cancer and various other solid tumors. It markets and sells Iclusig through specialty pharmacy in the United States. The company has license agreements with Medinol Ltd. to develop and commercialize stents and other medical devices to deliver ridaforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Cambridge, Massachusetts.

 

Stocks To Track: CONSOL Energy Inc. (CNX), CVS Health Corporation (CVS), MannKind Corporation (MNKD)

CONSOL Energy Inc. (CNX) fell -4.5% during last trading as the stock lost $-0.82 to finish the day at $17.41 with about 5.94M shares changing hands, compared to its three month average trading volume of 4.04M. The $4.1B market cap company, which fluctuated between $17.02 and $18.57 during the day, currently situated 284.01% above its 52 week low of $4.54 and -22.07% away from its one year high of $22.34. The RSI of 33.88 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CONSOL Energy Inc., together with its subsidiaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal. The E&P division produces pipeline quality natural gas primarily to gas wholesalers. This division owns rights to extract natural gas in Pennsylvania, West Virginia, and Ohio from approximately 436,000 net Marcellus Shale acres; and controls approximately 119,000 net acres of Utica Shale potential in eastern Ohio, as well as controls 113,000 net acres in Southwestern Pennsylvania and Northern West Virginia that contain the rights to the natural gas in Utica Shale; and owns rights to extract coalbed methane (CBM) in Virginia from approximately 268,000 net CBM acres, which cover a portion of its coal reserves in Central Appalachia. It also owns shallow oil and gas acreage position approximately 825,000 net acres in Illinois, Indiana, Kentucky, West Virginia, Pennsylvania, Virginia, and New York; various acres that have Upper Devonian potential; 116,000 net acres of Chattanooga Shale; and 380,000 net acres of Huron Shale potential in Kentucky, West Virginia, and Virginia, as well as provides midstream gas services. The Coal division engages in mining, preparation, and marketing of thermal coal primarily to power generators, and metallurgical coal to metal and coke producers. The company also provides energy services, including coal terminal services, water services, and land resource management services. CONSOL Energy Inc. was founded in 1864 and is headquartered in Canonsburg, Pennsylvania.

CVS Health Corporation (CVS) gained $1.44 to close the day at a new closing price of $80.35, a 1.82% increase in value from its previous closing price that moved the stock 15.95% above its 52 week low of $69.3. A total of 5.92M shares exchanged hands during the day compared with its three month average trading volume of 8.37M. The stock, which fluctuated between $78.97 and $80.45 during the day, currently situated -23.97% below its 52 week high. The stock is up by 4.68% in the past one month and down by -7.28% over the past three months. With a one year target estimate of $87.1 and RSI of 53.87, the stock still has upside potential, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

MannKind Corporation (MNKD) had a active trading with around 5.91M shares changing hands compared to its three month average trading volume of 4.99M. The stock traded between $0.6 and $0.675 before closing at the price of $0.63 with -0.83% change on the day. The Valencia California 91355 based company is currently trading 54% above its 52 week low of $0.41 and -71.81% below its 52 week high of $2.24. Both the RSI indicator and target price of 51.33 and $0 respectively, lead us to believe that it should be put on hold over the coming weeks.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.

 

Stocks in Review: Plug Power Inc. (PLUG), CVS Health Corporation (CVS), Texas Instruments Incorporated (TXN)

Plug Power Inc. (PLUG) traded within a range of $1.18 to $1.26 after opening the day at $1.25. The company has seen its stock decrease in value by -43.13% so far this year. The stock was down close to -1.64% on active volume in last trading session and closed at $1.2 per share. After the recent fall, the stock is currently holding -47.6% below its 52 week high of $2.28 and 1.69% above its 12-month low of $1.18. The shares are down by over -29.82% in the last three months, and the RSI indicator value of 33.33 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Plug Power Inc., an alternative energy technology provider, engages in the design, development, manufacture, and commercialization of fuel cell systems for the material handling and stationary power market in the United States. The company focuses on proton exchange membrane (PEM) fuel cell and fuel processing technologies, and fuel cell/battery hybrid technologies. Its product line includes GenKey, a turn-key solution for transitioning material handling vehicles to fuel cell power; GenDrive, a hydrogen fueled PEM fuel cell system that provides power to material handling vehicles; GenFuel, a hydrogen fueling delivery system; GenCare, which is an ongoing maintenance program for GenDrive fuel cells and GenFuel products; ReliOn, a stationary fuel cell solution that provides scalable and modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; and GenFund, which offers financing solutions to customers. The company sells its products to businesses and government agencies through direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.

CVS Health Corporation (CVS) continued its downward trend with the stock declining -0.11% or $-0.09 to close the day at $78.91 on light trading volume of 4.33M shares, compared to its three month average trading volume of 8.45M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -17.83%, compared to the industry which has advanced 5.14% over the same period. With RSI of 47.66, the stock should still continue to rise and get closer to its one year target estimate of $87.1, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Texas Instruments Incorporated (TXN) dropped $-1.18 to close the day at a new closing price of $72.97, a -1.59% decrease in value from its previous closing price that moved the stock 60.35% above its 52 week low of $46.73. A total of 4.31M shares exchanged hands during the day compared with its three month average trading volume of 5.16M. The stock, which fluctuated between $72.77 and $74.46 during the day, currently situated -3.03% below its 52 week high. The stock is down by -1.3% in the past one month and up by 4.74% over the past three months. With a one year target estimate of $74.89 and RSI of 50.91, the stock still has upside potential, making it a hold for now.

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing. The Analog segment offers high volume analog and logic products for automotive safety devices, touch screen controllers, low voltage motor drivers, and integrated motor controllers; and power management products that include catalog and application-specific standard products to enhance the efficiency of powered devices using battery management solutions, portable power conversion devices, power supply controls, and point-of-load products. This segment also provides high performance analog products, such as high-speed data converters, amplifiers, sensors, high reliability products, interface products, and precision products; and silicon valley analog products, including power management, data converter, interface, and operational amplifier catalog analog products that are used in manufacturing various electronic systems. The Embedded Processing segment offers microcontroller products, which are systems with a processor core, memory, and peripherals to control a set of specific tasks for electronic equipment; processor products comprising digital signal and applications processors; and connectivity products consisting of electronic devices to connect and transfer data. The company also provides DLP products primarily used in projectors to create high-definition images; application-specific integrated circuits; calculators; and baseband products, as well as OMAP applications processors and connectivity products. It markets and sells its products through a direct sales force and distributors. Texas Instruments Incorporated was founded in 1930 and is headquartered in Dallas, Texas.